2230197-64-3 (GLP-1 receptor agonist-1,GLP-1 receptor agonist 2)

化合物 T11407;

GLP-1 receptor agonist 2;GLP-1 receptor agonist-1;1H-Benzimidazole-6-carboxylic acid, 2-[[(2S)-4-[6-[(4-chloro-2-fluorophenyl)methoxy]-2-pyridinyl]-2-methyl-1-piperazinyl]methyl]-1-[(2S)-2-oxetanylmethyl]-;BDBM349672;CS-0062504;2230197-64-3;DA-53587;2-[[(2S)-4-[6-[(4-chloro-2-fluorophenyl)methoxy]pyridin-2-yl]-2-methylpiperazin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic acid;MS-30409;HY-112679;G16443;US10208019, Example 1A-19;2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid;AKOS040733261;SCHEMBL20266416;

IGXAOFNNKAUXCJ-CVDCTZTESA-N

1S/C30H31ClFN5O4/c1-19-15-36(27-3-2-4-29(34-27)41-18-21-5-7-22(31)14-24(21)32)11-10-35(19)17-28-33-25-8-6-20(30(38)39)13-26(25)37(28)16-23-9-12-40-23/h2-8,13-14,19,23H,9-12,15-18H2,1H3,(H,38,39)/t19-,23-/m0/s1

C1(CN2CCN(C3=NC(OCC4=CC=C(Cl)C=C4F)=CC=C3)C[C@@H]2C)N(C[C@@H]2CCO2)C2=CC(C(O)=O)=CC=C2N=1